Paper5114933
Reaction of protein disulfide groups with Ellman's reagent: a case study of the number of sulfhydryl and disulfide groups in Aspergillus oryzae -amylase, papain, and lysozyme.
Robyt JF and 2 others. Arch Biochem Biophys, 1971. Cited by 131 papers, by iCite.
Cite this record
ConductScience Library. Reaction of protein disulfide groups with Ellman's reagent: a case study of the number of sulfhydryl and disulfide groups in Aspergillus oryzae -amylase, papain, and lysozyme. Papers, record 5114933. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5114933
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Reaction of protein disulfide groups with Ellman's reagent: a case study of the number of sulfhydryl and disulfide groups in Aspergillus oryzae -amylase, papain, and lysozyme.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amylases | Major topic |
| Benzoates | Major topic |
| Indicators and Reagents | Major topic |
| Muramidase | Major topic |
| Papain | Major topic |
| Sulfhydryl Compounds | Major topic |
| Sulfides | Major topic |
| Aspergillus | |
| Disulfides | |
| Hydrogen-Ion Concentration | |
| Spectrophotometry |
Source PubMed
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 131 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42356509 | Application of In Silico QSAR and Molecular Docking Studies to a Series of Xanthine-Based Analogues and Design, Synthesis and Pharmacological Evaluation of Identified New Potential Selective MAO-B Inhibitors. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42356509 | PubMed |
| 42351972 | Novel Pyrrole-Based Hydrazide-Hydrazones: Synthesis, In Vitro Evaluation of Antioxidant and Neuroprotective Activity, In Silico ADME, and DFT Studies. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42351972 | PubMed |
| 41754706 | Synthesis of Comb-like and Coil-Comb Polystyrene-Polyglycidol Copolymers via Click Chemistry: Self-Assembly and Biological Evaluation. | Polymers (Basel) | 2026 | https://conductscience.org/library/papers/41754706 | PubMed |
| 41595599 | Antioxidant and Neuroprotective Capacity of Resveratrol-Loaded Polymeric Micelles in In Vitro and In Vivo Models with Generated Oxidative Stress. | Biomedicines | 2025 | https://conductscience.org/library/papers/41595599 | PubMed |
| 41516245 | Neuroprotective and Antioxidant Activity of Newly Synthesized N-Pyrrolyl Hydrazide-Hydrazones in Experimental Models of Neurotoxicity In Vitro and In Vivo. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516245 | PubMed |
| 41515483 | Evaluation of Pyrrole Heterocyclic Derivatives as Selective MAO-B Inhibitors and Neuroprotectors. | Molecules | 2026 | https://conductscience.org/library/papers/41515483 | PubMed |
| 41157086 | Phenolic Derivatives of Astragalus aitosensis with Selective MAO-B Inhibition and Mitochondrial Protection. | Molecules | 2025 | https://conductscience.org/library/papers/41157086 | PubMed |
| 40807329 | Classical Paal-Knorr Cyclization for Synthesis of Pyrrole-Based Aryl Hydrazones and In Vitro/In Vivo Evaluation on Pharmacological Models of Parkinson's Disease. | Molecules | 2025 | https://conductscience.org/library/papers/40807329 | PubMed |
| 40362198 | Antioxidant and Neuroprotective Properties of Selected Pyrrole-Containing Azomethine Compounds in Neurotoxicity Models In Vitro. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40362198 | PubMed |
| 40076286 | Flavonoids and Saponins from Two Chenopodium Species (C. foliosum Asch. and C. bonus-henricus L.)-Preliminary Evaluation for hMAO-A/B, Neuroprotective Activity, and Validated UHPLC-HRMS Quantification of Ethanolic Extract from C. foliosum. | Molecules | 2025 | https://conductscience.org/library/papers/40076286 | PubMed |
| 39339333 | Neurotoxicity, Neuroprotection, In Vitro MAOA/MAOB Inhibitory Activity Assessment, Molecular Docking, and Permeability Assay Studies of Newly Synthesized Hydrazones Containing a Pyrrole Ring. | Molecules | 2024 | https://conductscience.org/library/papers/39339333 | PubMed |
| 39292813 | Ellman's Assay on the Surface: Thiol Quantification of Human Cofilin-1 Protein through Surface Plasmon Resonance. | Langmuir | 2024 | https://conductscience.org/library/papers/39292813 | PubMed |
| 37512564 | Cycloartane Saponins from Astragalus glycyphyllos and Their In Vitro Neuroprotective, Antioxidant, and hMAO-B-Inhibiting Effects. | Metabolites | 2023 | https://conductscience.org/library/papers/37512564 | PubMed |
| 37107353 | New Indole-3-Propionic Acid and 5-Methoxy-Indole Carboxylic Acid Derived Hydrazone Hybrids as Multifunctional Neuroprotectors. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37107353 | PubMed |
| 36676090 | Newly Synthesized Creatine Derivatives as Potential Neuroprotective and Antioxidant Agents on In Vitro Models of Parkinson's Disease. | Life (Basel) | 2023 | https://conductscience.org/library/papers/36676090 | PubMed |
| 36500572 | In Silico Evaluation and In Vitro Determination of Neuroprotective and MAO-B Inhibitory Effects of Pyrrole-Based Hydrazones: A Therapeutic Approach to Parkinson's Disease. | Molecules | 2022 | https://conductscience.org/library/papers/36500572 | PubMed |
| 36014559 | Quantitative Structure-Neurotoxicity Assessment and In Vitro Evaluation of Neuroprotective and MAO-B Inhibitory Activities of Series N'-substituted 3-(1,3,7-trimethyl-xanthin-8-ylthio)propanehydrazides. | Molecules | 2022 | https://conductscience.org/library/papers/36014559 | PubMed |
| 35624746 | Study on the Neuroprotective, Radical-Scavenging and MAO-B Inhibiting Properties of New Benzimidazole Arylhydrazones as Potential Multi-Target Drugs for the Treatment of Parkinson's Disease. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/35624746 | PubMed |
| 33818516 | Evaluation of the combined activity of benzimidazole arylhydrazones as new anti-Parkinsonian agents: monoamine oxidase-B inhibition, neuroprotection and oxidative stress modulation. | Neural Regen Res | 2021 | https://conductscience.org/library/papers/33818516 | PubMed |
| 32118151 | Redox-Responsive Dipeptide Nanostructures toward Targeted Cancer Therapy. | ACS Omega | 2020 | https://conductscience.org/library/papers/32118151 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5114933
GET https://conductscience.org/api/papers/v1/5114933/cited_by?page=2